Skip to main content
Premium Trial:

Request an Annual Quote

Marc Malandro

Marc Malandro has been appointed to the advisory board of Helomics. Malandro is currently vice president of operations for science at the Chan Zuckerberg Initiative. He was the founding director of the Innovation Institute at the University of Pittsburgh, and vice chancellor for technology management and commercialization at the university. He also co-founded Sagres Discovery, a California-based systems biology company focused on understanding the molecular basis of cancer.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.